BioCanRx

11 communications in the past year

What they’re lobbying about

Continued funding for BioCanRx's Immunotherapy Network from various government funding opportunities to derisk immunotherapies, support made-in-Canada biomanufacturing and clinical trials, and training in translational research and commercialization.

— Stéphanie Michaud

Recent activity

Feb 24, 2026

Stéphanie Michaud contacted Salma Zahid

Feb 23, 2026

Stéphanie Michaud contacted Paul Hébert and Jeff Moore

Feb 20, 2026

Stéphanie Michaud contacted David MacFarlane and Manuela Tomic

Feb 18, 2026

Stéphanie Michaud contacted Shahad Khalladi

Feb 11, 2026

Stéphanie Michaud contacted Nipun Vats and Andrea Smith

Feb 9, 2026

Stéphanie Michaud contacted justine Frame and Jaeda Shilke

Feb 2, 2026

Stéphanie Michaud contacted Tony Baldinelli

Jul 11, 2023

Ujwal Ganguly contacted Dan Albas and Elizabeth Campbell

Jan 11, 2023

Kristina Proulx contacted Blake Oliver and Hadeel Aziz

Jan 10, 2023

Kristina Proulx contacted Glenn Purves and Fritz-Lionel Adimi

Toronto government contacts

Andrea SmithA/Director General, Innovation, Science and Economic Development Canada (ISED), Designated public office holder1

David MacFarlaneDirector of Policy, Innovation, Science and Economic Development Canada (ISED), Designated public office holder1

Jaeda ShilkeRegional Advisor, Health Canada (HC), Designated public office holder1

Jeff MooreAssociate Vice-President, Canadian Institutes of Health Research (CIHR), Designated public office holder1

Manuela TomicSenior Policy Advisor, Innovation, Science and Economic Development Canada (ISED), Designated public office holder1

Their lobbyists

Stéphanie MichaudIn-house11